Related Experiment Video
Updated: Apr 11, 2026

11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
39.7K
Treatment Satisfaction Among Patients with Moderate-to-severe Psoriasis
Tracey Finch1, Tang Ngee Shim1, Lesley Roberts2
1Solihull Hospital, Heart of England NHS Trust, Birmingham, United Kingdom.
The Journal of Clinical and Aesthetic Dermatology
|June 11, 2015
Summary
Patient satisfaction with psoriasis treatments varies. Phototherapy and systemic therapies show high satisfaction, while topical treatments have lower satisfaction, particularly concerning convenience.
Area of Science:
- Dermatology
- Patient-Reported Outcomes
Background:
- Psoriasis management involves various treatments, but patient satisfaction data is limited.
- Treatment dissatisfaction correlates with reduced adherence.
Purpose of the Study:
- To assess patient satisfaction levels across different psoriasis treatment modalities.
- To identify specific domains of satisfaction and dissatisfaction.
Main Methods:
- A modified, validated satisfaction questionnaire was administered to 38 psoriasis patients.
- Satisfaction was evaluated across topical, phototherapy, and systemic treatments, including safety, convenience, and information provision.
Main Results:
- Global satisfaction was significantly higher for phototherapy and systemic treatments compared to topical treatments.
- Twenty percent of patients on topical treatments reported dissatisfaction with convenience.
- Safety was the primary concern for patients on systemic therapies (biologics).
Conclusions:
- High satisfaction with phototherapy and systemic treatments is encouraging for clinicians and patients.
- Topical treatments exhibit higher dissatisfaction, despite their favorable safety profile.
- Future advancements should prioritize patient-reported concerns to improve compliance and potentially reduce healthcare costs.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
674
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
674
Drug Therapy
414
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
414

